| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0B | $10.7B | $9.3B | $8.4B | $2.0B | $2.0B | $1.8B | — |
| Cost of Revenue | $5.4B | $4.9B | $4.3B | $3.9B | $3.7B | $3.4B | $3.1B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.4B | $1.0B | $0.4B | $0.7B | $0.2B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.9B | $0.6B | $0.3B | $0.5B | $0.2B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $7.28 | $4.61 | $2.04 | $3.46 | $1.45 | $0.99 | $0.64 | $0.59 |
| EPS (Diluted) | $7.25 | $4.59 | $2.03 | $3.44 | $1.43 | $0.98 | $0.63 | $0.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.3B | $6.6B | $6.6B | $6.0B | $5.5B | $4.8B | $3.8B | $3.6B |
| Current Assets | $3.3B | $2.7B | $2.3B | $2.4B | $2.6B | $2.3B | $1.7B | $1.5B |
| Cash & Equivalents | $0.9B | $0.6B | $0.4B | $0.7B | $1.0B | $0.7B | $0.3B | $0.3B |
| Total Liabilities | $6.3B | $5.5B | $5.6B | $5.0B | $4.4B | $3.9B | $3.2B | $3.0B |
| Current Liabilities | $1.8B | $1.7B | $1.9B | $1.5B | $1.3B | $1.3B | $1.2B | $1.0B |
| Stockholders' Equity | $1.0B | $1.0B | $1.0B | $1.0B | $1.1B | $0.9B | $0.7B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.3B | $0.6B | $0.7B | $0.7B | $0.6B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.5B | $-0.9B | $-0.2B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.0B | $-0.4B | $-0.2B | $-0.3B | $0.0B | $-0.4B | $-0.2B |